This podcast describes the extended follow-up of the large International phase II CheckMate 205 study of single-agent nivolumab for patients with relapsed/refractory classical Hodgkin lymphoma after failure from autologous stem cell transplant. Read the <a href= "http://ascopubs.org/doi/10.1200/JCO.2017.76.0793">related article on JCO.org</a>.

This podcast describes the extended follow-up of the large International phase II CheckMate 205 study of single-agent nivolumab for patients with relapsed/refractory classical Hodgkin lymphoma after failure from autologous stem cell transplant. Read the related article on JCO.org.

This podcast describes the extended follow-up of the large International phase II CheckMate 205 study of single-agent nivolumab for patients with relapsed/refractory classical Hodgkin lymphoma after failure from autologous stem cell transplant. Read the <a href="http://ascopubs.org/doi/10.1200/JCO.2017.76.0793" rel="noopener noreferrer">related article on JCO.org</a>.

An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant

The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO's esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice.

The JCO Podcast also features in depth summaries and interviews hosted by the year's fellows in the series, JCO Article Insights.

Medicine

Health & Fitness

The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO's esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice. The JCO Podcast also features in depth summaries and interviews hosted by the year's fellows in the series, JCO Article Insights.

Share An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant

Sign up to save your podcasts

An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant

An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant

More shows like Journal of Clinical Oncology (JCO) Podcast

NPR News Now

JAMA Editors' Summary

NEJM This Week

JAMA Clinical Reviews

ASCO Daily News

The Daily

ASCO Guidelines

ASCO Education

Annals On Call Podcast

JAMA Medical News

Harrison's PodClass: Internal Medicine Cases and Board Prep

Run the List

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

The Headlines